… gefitinib and erlotinib, when efficacy and safety are factored, remains unknown. Therefore,
this study aimed … This study represents the first large cohort study to evaluate the efficacy and …

… We conducted a retrospective cohort study to assess the clinical outcomes of EGFR … and
EGFR exon20ins cohorts received first-generation EGFR TKIs erlotinib or gefitinib as their first …

… Materials & methods: We conducted a retrospective cohort study of linked administrative
health … and osimertinib, the present study only pertained to afatinib, erlotinib and gefitinib. …

… , these studies do not support subgroup analysis. Thus, this retrospective cohort study aimed
… PFS in patients treated with gefitinib [26], which was consistent with our study. Low BRAC1 …

… The EGFR TKI agents included afatinib, erlotinib, gefitinib, and osimertinib. Platinum-based …
In addition, this finding is consistent with a retrospective cohort study by Arunachalam et al. …

… We conducted a retrospective cohort study using multi-… treated with EGFR-TKIs (gefitinib,
erlotinib, afatinib). We defined … First-generation EGFR-TKIs (gefitinib and erlotinib) tended to …

… studies evaluating the efficacy and safety of gefitinib, erlotinib, and … study is the first to report
the efficacy and safety of gefitinib in … This reflects the fact that our cohort comprised real-world …

… gefitinib in EGFR-mutant NSCLC patients who progressed after first-generation EGFR-TKI.
Here we provide the efficacy data from the entire cohort… after gefitinib or erlotinib has been …

… gefitinib plus pemetrexed/platinum in our hospital between June 2015 and April 2020 were
consecutively enrolled in this study. … the efficacy of GPP, another cohort of 30 advanced lung …

… study was to evaluate the response with addition of newer generation of systemic targeted
agents (gefitinib and erlotinib… limitations of our study is that it was a small cohort study and the …